Rheumatoid arthritis is an autoimmune condition where your body’s immune system (which usually fights bacteria and viruses) attacks your body’s own cells. HCQS 200 Tablet stops that from happening and can relieve the symptoms of this condition such as pain, swelling, and stiffness in your joints. It can also slow down joint damage, reduce disability, and enable you to be as active for as long as possible. It can take several weeks or months to notice the effect of the medicine. You should continue taking it until your doctor says it is okay to stop using the medicine.
1. Treatment of Skin Conditions: HCQS (Hydroxychloroquine) tablets are used in dermatology to treat various skin conditions, including lupus erythematosus, rheumatoid arthritis, and other autoimmune disorders that affect the skin.
2. Anti-inflammatory Properties: Hydroxychloroquine has anti-inflammatory properties, which can help reduce inflammation associated with skin disorders, leading to symptom relief and improved skin health.
3. Immunosuppressive Effects: HCQS tablets can suppress the immune system's activity, helping to prevent autoimmune reactions that cause skin damage and inflammation.
4. Disease-modifying Effects: In addition to symptom relief, HCQS tablets may have disease-modifying effects, slowing down the progression of certain autoimmune skin diseases.
1. Hydroxychloroquine: The active ingredient in HCQS tablets, hydroxychloroquine, is a medication classified as an antimalarial and disease-modifying antirheumatic drug (DMARD). It is also used in dermatology to treat autoimmune skin disorders.
Warnings Of HCQS Tablets:
1. Retinal Toxicity: Prolonged use of HCQS tablets can lead to retinal toxicity, which may result in irreversible vision loss. Regular eye examinations are recommended to monitor for signs of retinal damage.
2. Cardiac Effects: HCQS tablets may cause cardiac side effects, including QT interval prolongation and cardiomyopathy. Caution is advised in patients with pre-existing cardiac conditions or a history of arrhythmias.
3. Hepatotoxicity: Rare cases of hepatotoxicity, including liver damage and elevated liver enzymes, have been reported with the use of HCQS tablets. Liver function tests may be recommended before and during treatment.
4. Dermatologic Reactions: HCQS tablets can sometimes cause dermatologic reactions, including photosensitivity, rash, and exacerbation of existing skin conditions. Patients should avoid prolonged exposure to sunlight and use sunscreen when outdoors.
5. Blood Disorders: HCQS tablets may rarely cause blood disorders such as agranulocytosis, thrombocytopenia, and aplastic anaemia. Patients should undergo regular blood tests to monitor for hematologic abnormalities.
Usage Of HCQS Tablets:
1. HCQS tablets should be taken exactly as prescribed by a dermatologist or healthcare provider.
2. The dosage and duration of treatment will vary depending on the specific skin condition being treated and the patient's individual response to therapy.
3. HCQS tablets are usually taken orally with food or a glass of milk to minimise gastrointestinal side effects.
4. It is important not to exceed the prescribed dosage or abruptly stop taking HCQS tablets without consulting a healthcare professional.
Side Effects Of HCQS Tablets:
1. Gastrointestinal Effects: Common side effects of HCQS tablets include nausea, vomiting, diarrhoea, and abdominal pain.
2. Dermatologic Reactions: Patients may experience skin rash, itching, or photosensitivity reactions when taking HCQS tablets.
3. Ocular Effects: Long-term use of HCQS tablets may increase the risk of ocular side effects, including retinopathy and vision changes.
4. Neuropsychiatric Effects: Rare neuropsychiatric side effects such as mood changes, anxiety, and hallucinations have been reported with the use of HCQS tablets.
Safety Information Of HCQS Tablets:
1. HCQS tablets should be used with caution in patients with a history of cardiac, hepatic, or hematologic disorders.
2. Patients should be monitored regularly for signs of adverse reactions, including ocular, cardiac, and dermatologic effects.
3. HCQS tablets should be stored in a cool, dry place away from moisture and sunlight.
4. Patients should inform their healthcare provider about all medications, supplements, and medical conditions before starting treatment with HCQS tablets.
Note: It is essential to read and follow the instructions provided with the specific brand or formulation of HCQS tablets and consult a dermatologist or healthcare professional for personalised advice regarding its use in dermatology.
Marketer Details
Name: Ipca Laboratories Ltd
Address: 142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
Country of origin: India
Expires on or after: July, 2026